Structural and drug-binding properties of α1-acid glycoprotein in reverse micelles

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1601, Issue 2, 2002, Pages 185-191

  Nishi, Koji ^a   Sakai, Norifumi ^a   Komine, Yoshio ^a   Maruyama, Toru ^a   Halsall, H Brian ^b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

1 Acid glycoprotein; Conformational transition; Drug binding; Reverse micelle

Indexed keywords

CHLORPROMAZINE; OROSOMUCOID; PROGESTERONE; SODIUM CHLORIDE; STEROID HORMONE; DICOUMAROL;

ACIDITY; ALPHA HELIX; ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; IONIC STRENGTH; LIGAND BINDING; PH; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVERSE MICELLE; CHEMISTRY; CIRCULAR DICHROISM; KINETICS; METABOLISM; MICELLE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE;

CHLORPROMAZINE; CIRCULAR DICHROISM; DICUMAROL; KINETICS; MICELLES; OROSOMUCOID; PROGESTERONE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

EID: 0037121465     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(02)00465-X     Document Type: Article

References (37)

1. Halsall H.B., Austin R.C., Dage J.L., Sun H., Schlueter K.T. Structural aspects of alpha 1-acid glycoprotein and its interactions. Otagiri M., Sugiyama Y., Testa B., Tillement J.-P. Proc. Int. Symp. on Serum Albumin and Alpha 1-Acid Glycoprotein, Kumamoto, Japan. 2000;45-54 Tokyo Print, Tokyo, Japan.
2. Kremer J.M., Wilting J., Janssen L.H. Drug binding to human alpha-1-acid glycoprotein in health and disease [Review]. Pharmacol. Rev. 40(1):1988;1-47.
3. Treuheit M.J., Costello C.E., Halsall H.B. Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem. J. 283(1):1992;105-112.
4. Clark A.J., Clissold P.M., Al Shawi R., Beattie P., Bishop J. Structure of mouse major urinary protein genes: different splicing configurations in the 3′-non-coding region. EMBO J. 3(5):1984;1045-1052.
5. Weisiger R., Gollan J., Ockner R. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. Science. 211(4486):1981;1048-1051.
6. Forker E.L., Luxon B.A. Albumin helps mediate removal of taurocholate by rat liver. J. Clin. Invest. 67(5):1981;1517-1522.
7. Forker E.L., Luxon B.A. Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface. J. Clin. Invest. 72(5):1983;1764-1771.
8. Horie T., Mizuma T., Kasai S., Awazu S. Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am. J. Physiol. 254(4 Pt. 1):1988;G465-G470.
9. Goto Y., Fink A.L. Conformational states of beta-lactoglobulin: molten-globule states at acidic and alkaline pH with high salt. Biochemistry. 28(3):1989;945-952.
10. Goto Y., Calciano L.J., Fink A.L. Acid-induced folding of proteins. Proc. Natl. Acad. Sci. U. S. A. 87(2):1990;573-577.
11. Goto Y., Fink A.L. Phase diagram for acidic conformational states of apomyoglobin. J. Mol. Biol. 214(4):1990;803-805.
12. Luisi P.L., Steinmann-Hofmann B. Activity and conformation of enzymes in reverse micellar solutions. Methods Enzymol. 136:1987;188-216.
13. Attallah N.A., Lata G.F. Steroid-protein interactions studies by fluorescence quenching. Biochim. Biophys. Acta. 168(2):1968;321-333.
14. Friedman M.L., Schlueter K.T., Kirley T.L., Halsall H.B. Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents. Biochem. J. 232(3):1985;863-867.
15. Halsall H.B., Villalobos A.P., Ivancic J.S., Bencosme A.I., Chung P. Monoclonal antibodies against human orosomucoid: tools for the exploration of structure, function and interactions. Baumann P., Muller W.E., Eap C.B., Tillement J.-P. Alpha-1-Acid Glycoprotein. Genetics, Biochemistry, Physiological Functions and Pharmacology. 1989;67-84 Alan R. Liss, New York.
16. Muzammil S., Kumar Y., Tayyab S. Molten globule-like state of human serum albumin at low pH. Eur. J. Biochem. 266(1):1999;26-32.
17. Matthews J.M., Norton R.S., Hammacher A., Simpson R.J. The single mutation Phe173-Ala induces a molten globule-like state in murine interleukin-6. Biochemistry. 39(8):2000;1942-1950.
18. Wallace L.A., Dirr H.W. Folding and assembly of dimeric human glutathione transferase A1-1. Biochemistry. 38(50):1999;16686-16694.
19. Predescu D., Predescu S., McQuistan T., Palade G.E. Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium. Proc. Natl. Acad. Sci. U. S. A. 95(11):1998;6175-6180.
20. Kemmink J., Creighton T.E. Local conformations of peptides representing the entire sequence of bovine pancreatic trypsin inhibitor and their roles in folding. J. Mol. Biol. 234(3):1993;861-878.
21. Ptitsyn O.B. Molten globule and protein folding. (Review, 423 references) Adv. Protein Chem. 47:1995;83-229.
22. London E. Diphtheria toxin: membrane interaction and membrane translocation. (Review, 216 references) Biochim. Biophys. Acta. 1113(1):1992;25-51.
23. Gray R.A., Vander Velde D.G., Burke C.J., Manning M.C., Middaugh C.R., Borchardt R.T. Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide. Biochemistry. 33(6):1994;1323-1331.
24. Jongh H.H., Killian J.A., Kruijff B. A water-lipid interface induces a highly dynamic folded state in apocytochrome c and cytochrome c, which may represent a common folding intermediate. Biochemistry. 31(6):1992;1636-1643.
25. Banuelos S., Muga A. Binding of molten globule-like conformations to lipid bilayers. Structure of native and partially folded alpha-lactalbumin bound to model membranes. J. Biol. Chem. 270(50):1995;29910-29915.
26. Jeffrey P.D., Bewley M.C., MacGillivray R.T., Mason A.B., Woodworth R.C., Baker E.N. Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin. Biochemistry. 37(40):1998;13978-13986.
27. Smith E.R., Storch J. Reversible pH-dependent conformational change of reconstituted influenza hemagglutinin. J. Mol. Biol. 260(3):1996;312-316.
28. Bychkova V.E., Berni R., Rossi G.L., Kutyshenko V.P., Ptitsyn O.B. Retinol-binding protein is in the molten globule state at low pH. Biochemistry. 31(33):1992;7566-7571.
29. Hamada D., Segawa S., Goto Y. Non-native alpha-helical intermediate in the refolding of beta-lactoglobulin, a predominantly beta-sheet protein. Nat. Struct. Biol. 3(10):1996;868-873.
30. Mottonen J., Strand A., Symersky J., Sweet R.M., Danley D.E., Geoghegan K.F., Gerard R.D., Goldsmith E.J. Structural basis of latency in plasminogen activator inhibitor-1. Nature. 355(6357):1992;270-273.
31. Berkenpas M.B., Lawrence D.A., Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO. J. 14(13):1995;2969-2977.
32. Prusiner S.B. Scrapie prions. Annu. Rev. Microbiol. 43:1989;345-374.
33. Morillas M., Swietnicki W., Gambetti P., Surewicz W.K. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274(52):1999;36859-36865.
34. Sanghera N., Pinheiro T.J. Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315(5):2002;1241-1256.
35. Bennett M., Schmid K. Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety. Proc. Natl. Acad. Sci. U. S. A. 77(10):1980;6109-6113.
36. Andersen M.M. Leucocyte-associated plasma proteins. Association of prealbumin, albumin, orosomucoid, alpha 1-antitrypsin, transferrin and haptoglobin with human lymphocytes, monocytes, granulocytes and a promyelocytic leukaemic cell line (HL 60). Scand. J. Clin. Lab. Invest. 43(1):1983;49-59.
37. Andersen M.M. Leucocyte-associated plasma proteins in leucocytes during disease states, and in leukaemic cells. Scand. J. Clin. Lab. Invest. 44(3):1984;257-265.